Defence of mucous membranes by antibodies, receptor analogues and non-specific host factors L.Å HansonB. AnderssonL. Mellander OriginalPaper Pages: S166 - S170
Genetic factors in host resistance to urinary tract infection Catharina Svanborg EdénL. HagbergS. Michalec OriginalPaper Pages: S171 - S176
T cell clones and their products: Experimental clues for the immunoprophylaxis and immunotherapy of intracellular bacterial infections? S. H. E. Kaufmann OriginalPaper Pages: S177 - S183
Protection against facultative intracellular bacteria — Role of macrophage activation and granuloma formation OriginalPaper Pages: S184 - S184
In vitro and in vivo effect of immunoglobulin G on the integrity of bacterial membranes A. Dalhoff OriginalPaper Pages: S185 - S193
Indirect evidence of cell wall alterations in pseudomonas aeruginosa by immunoglobulin preparations G. Stübner OriginalPaper Pages: S194 - S195
Non-antibiotic prevention of urinary tract infection L. HagbergCatharina Svanborg EdénH. Leffler OriginalPaper Pages: S196 - S201
P-fimbriae studies on the diagnosis and prevention of acute pyelonephritis Gunilla KälleniusS. B. SvensonK. Tullus OriginalPaper Pages: S202 - S205
Oral vaccination against enteric bacterial infections: An overview R. Germanier OriginalPaper Pages: S206 - S210
Prevention and treatment of cytomegalovirus infections with interferons and immune globulins J. D. Meyers OriginalPaper Pages: S211 - S218
Interleukin 2 therapy in infectious diseases: Rationale and prospects J. P. SiegelA. H. RookG. V. Quinnan Jr. OriginalPaper Pages: S219 - S223
Monoclonal antibodies: Technology and application to gram-negative infections L. S. Young OriginalPaper Pages: S224 - S229
Immunoprophylaxis and immunotherapy of neonatal group B streptococcal infections S. P. Gotoff OriginalPaper Pages: S230 - S235
In vitro investigations on the antibacterial action and the influence on the phagocytic chemiluminescence of tetrachlorodecaoxide — A new, non-metallic oxygen complex U. UllmannF. W. Kühne OriginalPaper Pages: S236 - S240
The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections J. Drews OriginalPaper Pages: S241 - S250
Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents Monique ParantL. Chedid OriginalPaper Pages: S251 - S255
Studies on immunity against escherichia coli K13 with monoclonal Anti-K13 and Anti-anti-K13 T. SöderströmL.Å HansonR. Schneerson OriginalPaper Pages: S256 - S259
